events
05 July 2022
Jean De Gunzburg speaker at the 8th Annual Microbiome Connect Europe 2022 on July 6 at 11.30am CET
Jean De Gunzburg will attend the 8th Annual Microbiome Connect: Europe 2022 on July 6-7 2022 and participate as a…
The US Patent and Trademark Office has recently granted a new patent for Da Volterra in the USA. The patent was issued under number 10,052,288 and relates to DAV132, our phase 2 asset to protect the intestinal microbiota from antibiotic-induced disruption.
This new patent reinforces our intellectual property portfolio and comes as a complement to the already 100+ patents protecting our products worldwide.
